Is UNII-4U3D3YY81M Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use UNII-4U3D3YY81M? Is UNII-4U3D3YY81M safe for nursing mother and child? Does UNII-4U3D3YY81M extracts into breast milk? Does UNII-4U3D3YY81M has any long term or short term side effects on infants? Can UNII-4U3D3YY81M influence milk supply or can UNII-4U3D3YY81M decrease milk supply in lactating mothers?

Antibacterial glycopeptide, administered via intravenous or intramuscularinjection. Its pharmacokinetic data (high molecular weight, high percentage of plasma protein binding and no oral bioavailability) explain the negligible passage into milk observed (Fraissinet 2017) and the absence of side effects in a 52-day-old infant whose mother was being treated with UNII-4U3D3YY81M (Kaplan 2017). Not being absorbed orally, there would be no passage to the infant's plasma from ingested breast milk. It is an antibiotic that is administered, if necessary, to newborns. The possible negativity of cultures in febrile infants whose mothers take antibiotics should be taken into account, as well as the possibility of gastroenteritis due to altered intestinal flora.

UNII-4U3D3YY81M is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. Limited data indicate that UNII-4U3D3YY81M is poorly excreted into breastmilk. Because UNII-4U3D3YY81M is not orally absorbed it is unlikely to adversely affect the breastfed infant. One infant was safely breastfed during maternal therapy with UNII-4U3D3YY81M and ceftriaxone. Until more information becomes available, monitor the breastfed infant for gastrointestinal disturbances such as diarrhea, particularly in newborn and preterm infants.

A mother who was exclusively nursing her 52-day-old infant developed a soft-tissue infection. She was treated with intravenous UNII-4U3D3YY81M 400 mg every 12 hours for 3 doses, then 400 mg daily for 5 days total, intravenous ceftriaxone 1 gram daily, and topical mupirocin cream twice daily. A careful follow-up indicated that her infant had no adverse effects.[2]